BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27419396)

  • 1. Adherence to Long-Acting Bronchodilators After Discharge for COPD: How Much of the Geographic Variation is Attributable to the Hospital of Discharge and How Much to the Primary Care Providers?
    Di Martino M; Ventura M; Cappai G; Lallo A; Davoli M; Agabiti N; Fusco D
    COPD; 2017 Feb; 14(1):86-94. PubMed ID: 27419396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to evidence-based drug therapies after myocardial infarction: is geographic variation related to hospital of discharge or primary care providers? A cross-classified multilevel design.
    Di Martino M; Alagna M; Cappai G; Mataloni F; Lallo A; Perucci CA; Davoli M; Fusco D
    BMJ Open; 2016 Apr; 6(4):e010926. PubMed ID: 27044584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
    BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use patterns of long-acting bronchodilators in routine COPD care: the OUTPUL study.
    Di Martino M; Agabiti N; Bauleo L; Kirchmayer U; Cascini S; Pistelli R; Colamesta V; Patorno E; Pinnarelli L; Fusco D; Perucci CA; Davoli M;
    COPD; 2014 Aug; 11(4):414-23. PubMed ID: 24090036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care.
    Punekar YS; Landis SH; Wurst K; Le H
    Respir Res; 2015 Nov; 16():141. PubMed ID: 26572740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibiotic prescription in pediatric outpatients in Italy: the role of local health districts and primary care physicians in determining variation. A multilevel design for healthcare decision support.
    Di Martino M; Lallo A; Kirchmayer U; Davoli M; Fusco D
    BMC Public Health; 2017 Nov; 17(1):886. PubMed ID: 29149875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary Disease.
    Arfè A; Nicotra F; Cerveri I; de Marco R; Vaghi A; Merlino L; Corrao G
    COPD; 2016 Oct; 13(5):540-6. PubMed ID: 26934569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
    Di Martino M; Agabiti N; Cascini S; Kirchmayer U; Bauleo L; Fusco D; Belleudi V; Pinnarelli L; Voci C; Patorno E; Pistelli R; Davoli M;
    COPD; 2016 Jun; 13(3):293-302. PubMed ID: 26514912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Decision Support System: A Pragmatic Tool to Improve Acute Exacerbation of COPD Discharge Recommendations.
    Epstein D; Barak-Corren Y; Isenberg Y; Berger G
    COPD; 2019 Feb; 16(1):18-24. PubMed ID: 30947556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Quebec Respiratory Health Education Network: Integrating a model of self-management education in COPD primary care.
    Bourbeau J; Farias R; Li PZ; Gauthier G; Battisti L; Chabot V; Beauchesne MF; Villeneuve D; Côté P; Boulet LP
    Chron Respir Dis; 2018 May; 15(2):103-113. PubMed ID: 28750556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease.
    Brown KE; Johnson KJ; DeRonne BM; Parenti CM; Rice KL
    Ann Am Thorac Soc; 2016 Jun; 13(6):811-5. PubMed ID: 27058777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients.
    Kim J; Kim K; Kim Y; Yoo KH; Lee CK; Yoon HK; Kim YS; Park YB; Lee JH; Oh YM; Lee SD; Lee SW
    Respir Med; 2014 Jan; 108(1):153-61. PubMed ID: 23993445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
    Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
    Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
    Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice : an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder.
    Incalzi RA; Corsonello A; Pedone C; Masotti G; Bellia V; Grassi V; Rengo F
    Drugs Aging; 2006; 23(5):411-20. PubMed ID: 16823994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
    Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
    COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adherence to long-term therapies and its relevance to epidemiology.].
    Di Martino M
    Recenti Prog Med; 2017 Apr; 108(4):165-167. PubMed ID: 28492583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.